(VIANEWS) – SEADRILL (SDRL.OL), NEOEN (NEOEN.PA), REACH SUBSEA (REACH.OL) are the highest sales growth and return on equity stocks on this list.
Here is a list of stocks with an above 5% expected next quarter sales growth, and a 3% or higher return on equity. May these stocks be a good medium-term investment option?
1. SEADRILL (SDRL.OL)
66% sales growth and 4.22% return on equity
Seadrill Limited provides offshore contract drilling services to the oil and gas industry worldwide. It operates in three segments: Harsh Environment, Floaters, and Jack-ups Rigs. The company owns and operates drill ships, semi-submersible rigs, and jack-up rigs for operations in shallow and ultra-deep-water in benign and harsh environments. It serves oil super-majors, state-owned national oil companies, and independent oil and gas companies. Seadrill Limited was formerly known as Seadrill 2021 Limited. The company was incorporated in 2005 and is headquartered in Hamilton, Bermuda.
Earnings Per Share
As for profitability, SEADRILL has a trailing twelve months EPS of kr623.05.
PE Ratio
SEADRILL has a trailing twelve months price to earnings ratio of 0.82. Meaning, the purchaser of the share is investing kr0.82 for every norwegian krone of annual earnings.
Return on Equity
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 4.22%.
Growth Estimates Quarters
The company’s growth estimates for the current quarter and the next is 361.5% and 251%, respectively.
Earnings Before Interest, Taxes, Depreciation, and Amortization
SEADRILL’s EBITDA is 227.07.
Volume
Today’s last reported volume for SEADRILL is 54148 which is 66.5% below its average volume of 161664.
Yearly Top and Bottom Value
SEADRILL’s stock is valued at kr512.00 at 07:20 EST, under its 52-week high of kr550.00 and way higher than its 52-week low of kr228.00.
More news about SEADRILL.
2. NEOEN (NEOEN.PA)
48.5% sales growth and 7.39% return on equity
Neoen S.A., an independent renewable energy production company, engages in the development and operation of renewable energy power plants. The company operates through Solar Power, Wind Power, Storage, Farm-Down, Development and Investments, and Eliminations segments. It operates in Argentina, Australia, Canada, Ecuador, the United States, Finland, France, Ireland, Italy, Jamaica, Mexico, Mozambique, Portugal, El Salvador, Sweden, and Zambia. Neoen S.A. was incorporated in 2008 and is headquartered in Paris, France. Neoen S.A. operates as a subsidiary of Impala SAS.
Earnings Per Share
As for profitability, NEOEN has a trailing twelve months EPS of €1.14.
PE Ratio
NEOEN has a trailing twelve months price to earnings ratio of 24.32. Meaning, the purchaser of the share is investing €24.32 for every euro of annual earnings.
Return on Equity
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 7.39%.
More news about NEOEN.
3. REACH SUBSEA (REACH.OL)
19.4% sales growth and 24.57% return on equity
Reach Subsea ASA provides subsea services in Norway and internationally. It operates in two segments, Oil & Gas and Renewable/Other. The company offers inspection, maintenance, and repair services, such as structural inspections, WROV operation, SCM changeout, scale squeeze operations, water injection, ready for operation, subsea equipment maintenance, repair, commissioning, and boulder clearance; and construction support services, including seabed intervention, boulder clearance, touchdown monitoring, and pre-lay and post- lay survey, as well as vessel, remotely operated vehicles, personnel, survey, and on demand engineering. It also provides asset integrity/pipeline inspection, and engineering and project management services; reach remote services comprising survey, inspection, and IMR and seabed intervention; seabed survey services consisting of site surveys and geohazard investigation, pipeline inspection, seabed mapping, UXO, general, and route surveys; offshore cable; marine construction; and rig and mooring services. In addition, the company offers geophysical monitoring services, which include 4D gravity, seafloor subsidence monitoring, depth watch for seismic nodes, injection integrity monitoring, well drilling, and real time seismic monitoring services; and environmental monitoring services that comprise earthquake monitoring and prediction, C02 storage, and geothermal energy exploitation. It serves oil and gas, renewables, and utilities sectors. The company was formerly known as Transit Invest ASA and changed its name to Reach Subsea ASA in December 2012. Reach Subsea ASA was incorporated in 1909 and is headquartered in Haugesund, Norway.
Earnings Per Share
As for profitability, REACH SUBSEA has a trailing twelve months EPS of kr0.67.
PE Ratio
REACH SUBSEA has a trailing twelve months price to earnings ratio of 6.76. Meaning, the purchaser of the share is investing kr6.76 for every norwegian krone of annual earnings.
Return on Equity
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 24.57%.
Earnings Before Interest, Taxes, Depreciation, and Amortization
REACH SUBSEA’s EBITDA is 1.54.
Moving Average
REACH SUBSEA’s value is way higher than its 50-day moving average of kr4.03 and above its 200-day moving average of kr4.19.
Sales Growth
REACH SUBSEA’s sales growth for the next quarter is 19.4%.
More news about REACH SUBSEA.
4. NAVAMEDIC (NAVA.OL)
17.3% sales growth and 10.19% return on equity
Navamedic ASA, a pharmaceutical company, develops, produces, markets, and sells pharmaceuticals and related products in Northern Europe. The company's product portfolio includes prescription and non-prescription pharmaceuticals, as well as medical nutrition products, medical devices, food supplements, and cosmetics. It offers medical nutrition products for various therapeutic areas, including phenylketonuria, homocystinuria, maple syrup urine disease, tyrosinemia, methylmalonic acidemia/propionic acidemia, glutaric aciduria, isovaleric acidemia, and urea cycle disorders, as well as products for glycogen storage diseases and renal diseases, fat metabolism, malnutrition, and ketogenic diet. In addition, the company provides consumer health products consisting of non-prescription drugs and health care products for pain relief, cough and cold, gastro, obesity, women's health, and others primarily through pharmacies and drugstores; specialty pharmaceutical products in various therapeutic areas comprising dermatology, wound care, urology, and obesity; and branded generics, including cardiology products and antibiotics. It sells, markets, and distributes its products to hospitals, patients, and pharmacies. The company was formerly known as Glucomed AS and changed its name to Navamedic ASA in 2004. Navamedic ASA was incorporated in 2002 and is headquartered in Oslo, Norway.
Earnings Per Share
As for profitability, NAVAMEDIC has a trailing twelve months EPS of kr1.18.
PE Ratio
NAVAMEDIC has a trailing twelve months price to earnings ratio of 32.46. Meaning, the purchaser of the share is investing kr32.46 for every norwegian krone of annual earnings.
Return on Equity
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 10.19%.
Yearly Top and Bottom Value
NAVAMEDIC’s stock is valued at kr38.30 at 07:20 EST, way below its 52-week high of kr43.60 and way above its 52-week low of kr29.20.
Sales Growth
NAVAMEDIC’s sales growth is 22.8% for the ongoing quarter and 17.3% for the next.
More news about NAVAMEDIC.
5. MULTICONSULT (MULTI.OL)
10% sales growth and 34.44% return on equity
Multiconsult ASA provides engineering design, consultancy, and architecture services in Norway and internationally. The company offers multidisciplinary consultancy, design, planning, project supervision and management, geotechnical site survey, verification and control, analysis and due diligence, construction management, geological investigations, environmental services and HSE, river basin management, hydrometry, and hydrological field work services. It serves buildings and properties, cities and society, industry, oil and gas, renewable energy, rail and transportation, and water and environment sectors. Multiconsult ASA was founded in 1908 and is headquartered in Oslo, Norway.
Earnings Per Share
As for profitability, MULTICONSULT has a trailing twelve months EPS of kr11.19.
PE Ratio
MULTICONSULT has a trailing twelve months price to earnings ratio of 12.69. Meaning, the purchaser of the share is investing kr12.69 for every norwegian krone of annual earnings.
Return on Equity
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 34.44%.
Volume
Today’s last reported volume for MULTICONSULT is 1720 which is 61.51% below its average volume of 4469.
Earnings Before Interest, Taxes, Depreciation, and Amortization
MULTICONSULT’s EBITDA is 0.97.
Sales Growth
MULTICONSULT’s sales growth for the next quarter is 10%.
More news about MULTICONSULT.
6. KONGSBERG GRUPPEN (KOG.OL)
9.2% sales growth and 26.05% return on equity
Kongsberg Gruppen ASA, together with its subsidiaries, provides high-tech systems and solutions primarily to customers in the maritime and defense markets. The company operates through three segments: Kongsberg Maritime, Kongsberg Defence & Aerospace, and Other. The Kongsberg Maritime segment offers solutions and systems for bridge and control systems, which include dynamic positioning, propulsion control, and navigation, as well as automation systems; energy solutions and ship design services; and propellers, thrusters, water jet systems, and systems for offshore manoeuvring of maritime vessels. This segment also provides winches for mooring, anchor handling, and special systems for offshore vessels, tugs, marine vessels, and various other classes of vessel, as well as cranes; hydroacoustics; autonomous underwater vessels and solutions for autonomous maritime vessels; and products related to fisheries, systems for underwater mapping, and sensors and solutions for specialist vessels. The Kongsberg Defence & Aerospace segment offers various systems and services to the defense industry. It provides air defense and combat systems, sonars, and navigation for marine vessels and submarines, as well as integrated command and control systems; remote tower solutions for airports; remote control weapon stations for land-based vehicles and marine vessels; products for military tactical communication; naval strike and air-to-surface missiles; and lightweight composite and titanium components for F-35 combat aircraft. This segment also offers components and services to the space industry, as well as port monitoring systems; and maintenance, repair, and overhaul services. The Other segment focuses on digitalization within the oil and gas, wind, and merchant marine markets. It operates primarily in Norway, Europe, North America, South America, Asia, Australia, and Africa. Kongsberg Gruppen ASA was founded in 1814 and is headquartered in Kongsberg, Norway.
Earnings Per Share
As for profitability, KONGSBERG GRUPPEN has a trailing twelve months EPS of kr19.14.
PE Ratio
KONGSBERG GRUPPEN has a trailing twelve months price to earnings ratio of 24.66. Meaning, the purchaser of the share is investing kr24.66 for every norwegian krone of annual earnings.
Return on Equity
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 26.05%.
More news about KONGSBERG GRUPPEN.
7. MEDISTIM (MEDI.OL)
5.1% sales growth and 31.89% return on equity
Medistim ASA develops, produces, services, leases, and distributes medical devices for cardio-vascular surgery in the United States, Europe, Asia, and internationally. It offers MiraQ Cardiac, a system that combines ultrasound imaging and transit time flow measurement (TTFM) in a single system for cardiac surgery; MiraQ Vascular, a system that combines ultrasound imaging and transit TTFM in a single system for vascular surgery; and imaging probes for intraoperative use. The company also provides various flow probes, such as QuickFit TTFM probes to accurately measure blood volume flow intraoperatively in various range of surgical applications; Vascular TTFM probes for enhancing surgical outcomes; and doppler probes that are used on the surface of the heart/vessel to search for intramural coronary arteries or to locate the position and quantify the degree of a stenosis. In addition, it distributes and sells third party medical equipment. The company was incorporated in 1984 and is headquartered in Oslo, Norway.
Earnings Per Share
As for profitability, MEDISTIM has a trailing twelve months EPS of kr6.41.
PE Ratio
MEDISTIM has a trailing twelve months price to earnings ratio of 34.17. Meaning, the purchaser of the share is investing kr34.17 for every norwegian krone of annual earnings.
Return on Equity
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 31.89%.
More news about MEDISTIM.
